(Q51025796)

English

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.

scientific article published in May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

multiple sclerosis

0 references

object named as

Michael Hecker

1

0 references

author name string

Christiane Hartmann

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Ole Kandulski

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Brigitte Katrin Paap

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Dirk Koczan

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Hans-Juergen Thiesen

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Uwe Klaus Zettl

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

publication date

1 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

48

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

737-756

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

https://scigraph.springernature.com/pub.10.1007/s12035-013-8463-1

0 references

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Multiple sclerosis: a complicated picture of autoimmunity.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Immune-mediated CNS diseases: a review on nosological classification and clinical features

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Viral triggers of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

PEGylation of Interferon-β-1a

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Interferons at age 50: past, current and future impact on biomedicine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

A diverse range of gene products are effectors of the type I interferon antiviral response

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Interferon-beta mechanisms of action in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Determinants of interferon β efficacy in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Biomarkers of disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Systematic review of genome-wide expression studies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Differential gene expression and translational approaches to identify biomarkers of interferon beta activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Gene expression profiles reveal homeostatic dynamics during interferon-beta therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Novel definition files for human GeneChips based on GeneAnnot

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Integrative modeling of transcriptional regulation in response to antirheumatic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Using GOstats to test gene lists for GO term association

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

A HaemAtlas: characterizing gene expression in differentiated human blood cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The UCSC Genome Browser database: extensions and updates 2011.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

cisRED: a database system for genome-scale computational discovery of regulatory elements

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

SwissRegulon: a database of genome-wide annotations of regulatory sites

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

STAMP: a web tool for exploring DNA-binding motif similarities

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

GeneCards Version 3: the human gene integrator

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Cytoscape 2.8: new features for data integration and network visualization

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

An automated method for finding molecular complexes in large protein interaction networks

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

clusterMaker: a multi-algorithm clustering plugin for Cytoscape

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Complex roles of Stat1 in regulating gene expression

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Evidence for a two-stage disability progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Development of resistance to biologic therapies with reference to IFN-β.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Neutralising antibodies to interferon beta during the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The protooncogene TCL1 is an Akt kinase coactivator

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Type I interferon (IFN-alpha/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta/Akt, Rho-A, NFkappaB and Bcl-2/Bcl(XL).

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Reciprocal regulation between natural killer cells and autoreactive T cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Granzyme B activity in target cells detects attack by cytotoxic lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

NK cells, MHC class I molecules and the missing self

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Major differences in the responses of primary human leukocyte subsets to IFN-beta.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Monocyte chemoattractant protein-1 (MCP-1): an overview

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Viperin: a multifunctional, interferon-inducible protein that regulates virus replication

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

New developments in the induction and antiviral effectors of type I interferon

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

OAS1: a multiple sclerosis susceptibility gene that influences disease severity.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The ISG56/IFIT1 gene family

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The role of protein kinase R in the interferon response

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

PKR and the ribosome compete for mRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Antiproliferative activity of the human IFN-alpha-inducible protein IFI44.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Targeting apoptosis to treat multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Interleukin-8, a chemotactic and inflammatory cytokine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Increased CXCL8 (IL-8) expression in Multiple Sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Extracellular matrix remodelling: the role of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Complement and its role in innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Complement: a key system for immune surveillance and homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

A direct role for C1 inhibitor in regulation of leukocyte adhesion.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Capture, crawl, cross: the T cell code to breach the blood-brain barriers

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The IRF family, revisited

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Regulation and functions of Blimp-1 in T and B lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

BLIMP1 guides the fate of effector B and T cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

PRDM1/BLIMP-1 modulates IFN-gamma-dependent control of the MHC class I antigen-processing and peptide-loading pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

The SANT domain: a unique histone-tail-binding module?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Sensing of viral nucleic acids by RIG-I: from translocation to translation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Immune signaling by RIG-I-like receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

An Atomic Model of the Interferon-β Enhanceosome

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Interferon-stimulated gene 15 and the protein ISGylation system

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

RNA-Seq: a revolutionary tool for transcriptomics

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

C1 inhibitor, a multi-functional serine protease inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Opposite effects of interferon-beta on new B and T cell release from production sites in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8463-1

21 January 2018

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of B cell receptor-mediated apoptosis by IFN.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New developments in FcepsilonRI regulation, function and inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Within the fold: assessing differential expression measures and reproducibility in microarray assays.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunology of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential induction of interferon (IFN)-inducible protein 10 following differentiation of a monocyte, macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/23636981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-013-8463-1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23636981

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51025796&oldid=2121569710"